Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 1, 2004, Pages 158-164

  Suzuki, M ^a   Suzuki, H ^b   Masaoka, T ^b   Tanaka, S ^a   Suzuki, K ^a   Ishii, H ^b  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; FAMOTIDINE; KI 67 ANTIGEN; LANSOPRAZOLE; MYELOPEROXIDASE; OMEPRAZOLE; PROTON PUMP INHIBITOR; SCATTER FACTOR;

CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; ERADICATION THERAPY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH EPITHELIUM; STOMACH MUCOSA; TISSUE LEVEL;

EID: 4344669660     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01971.x     Document Type: Conference Paper

References (19)

1. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
2. Honda S, Fujioka T, Tokieda M, et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-9.
3. Personnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of adenocarcinoma. N Eng J Med 1991; 325: 1127-31.
4. Nomura A, Stemmermann GN, Chyou P-H, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Eng J Med 1991; 325: 1132-6.
5. Kim JJ, Tao H, Carloni E, et al. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002; 123: 542-53.
6. Drake IM, Mapstone NP, Schorah CJ, et al. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication. Gut 1998; 42: 768-71.
7. Scotiniotis IA, Rokkas T, Furth EE, et al. Altered gastric epithelial cell kinetics in Helicobacter pylori-associated intestinal metaplasia: Implications for gastric carcinogenesis. Int J Cancer 2000; 85: 192-200.
8. Dignass AU, Lynch-Devaney K, Podolsky DK. Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 1994; 202: 701-9.
9. Yasunaga Y, Shinomura Y, Kanayama S, et al. Increased production of interleukin 1β and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut 1996; 39: 787-94.
10. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MH53) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-63.
11. Sung JJY, Lin SR, Ching JYL, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7-14.
12. Ito M, Haruma K, Kamada T, et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002; 16: 1449-56.
13. Matsumoto K, Nakamura T. Pleiotrophic roles of HGF in autogenesis, morphogenesis and organ regeneration. Gann Monogr Cancer Res 1994; 42: 91-112.
14. Tamura M, Arakaki N, Tsubouchi H, et al. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J Bio Chem 1993; 268: 8140-5.
15. Chen JH, Liu TY, Wu CW, et al. Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression. Med Hypotheses 2001; 57: 503-5.
16. Taha AS, Curry GW, Morton R, et al. Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease. Am J Gastroenterol 1996; 91: 1407-9.
17. Nordone G, Staibano S, Rocco A, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999; 44: 789-99.
18. Fraser AG, Sim R, Sankey EA, et al. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther 1994; 8: 167-73.
19. Yoshimura T, Shimoyama T, Tanaka M, et al. Gastric mucosal inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infection. J Clin Pathol 2000; 53: 532-6.